First Horizon Advisors, Inc. Invitae Corp Transaction History

First Horizon Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.42 - $0.72 $637 - $1,092	-1,518 Reduced 24.42%	4,698 $2,000
Q3 2023 Oct 27, 2023	SELL	$0.6 - $1.53 $2,407 - $6,138	-4,012 Reduced 39.23%	6,216 $3,000
Q2 2023 Aug 03, 2023	SELL	$1.05 - $1.63 $1,221 - $1,895	-1,163 Reduced 10.21%	10,228 $11,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $609 - $1,386	508 Added 4.67%	11,391 $15,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $5,071 - $10,707	2,966 Added 37.46%	10,883 $20,000
Q3 2022 Nov 09, 2022	SELL	$1.9 - $8.63 $1,274 - $5,790	-671 Reduced 7.81%	7,917 $19,000
Q2 2022 Aug 02, 2022	BUY	$2.13 - $9.01 $18,292 - $77,377	8,588 New	8,588 $20,000
Q1 2022 May 10, 2022	SELL	$6.28 - $15.59 $22,651 - $56,233	-3,607 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $5,042 - $9,833	343 Added 10.51%	3,607 $55,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $42,955 - $59,371	1,767 Added 118.04%	3,264 $92,000
Q3 2021 Nov 09, 2021	SELL	$24.31 - $33.6 $11,231 - $15,523	-462 Reduced 23.58%	1,497 $42,000
Q2 2021 Aug 09, 2021	BUY	$26.09 - $40.4 $20,689 - $32,037	793 Added 68.01%	1,959 $66,000
Q1 2021 May 11, 2021	BUY	$33.06 - $56.93 $38,547 - $66,380	1,166 New	1,166 $44,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.